“Healthcare/Life Sciences Industry : Preparing for 2019

December 18th (Tuesday) 12:30 PM – 4:30 PM

Yale Club Manhattan, Roof Dining Room & Terrace 22nd FL

 

New York Health Forum (NYHF) is founded to strengthen healthcare partnerships and knowledge sharing at all levels, including industry, academia, medical facilities, research facilities, service providers and financial investors. New York Health Forum’s mission is to present the significant agendas of the healthcare industry, to contribute to the public health by bringing out the public concerns to be discussed and solved; and to gather the sound of health policy, science innovation, and industry development. Our 11th New York Health Forum’s title is “Healthcare/Life Sciences Industry : Preparing for 2019.” This forum will provide the setting for stimulating and informative discussions on the investment trends, landscapes, risks, and more. Around one hundred of investors, biopharma and medtech representatives, healthcare professionals will come together to connect, learn, and share.

 

Program

12: 30 PM – 1:00 PM Network Reception and Lunch 

 

1:00 PM – 1:10 PM Opening Statement

“Healthcare and Lifesciences Current Trend and Forecasting 2019”

  • DoHyun Cho, PhD (Chairman, New York Health Forum)

 

1:10 PM – 2:00 PM Session 1 

“Key Trends in Therapeutic Deal Making”

Licensing in therapeutic companies is being used as a key growth strategy to improve their market position and strengthen their financial and business market values. Industry executives and experts will join as panels in this session to discuss about current deal trends and prospects in the 2019.

  • Moderator: Joe McMenamin, MD, JD (EVP, W Medical Strategy Group)

 

2:00 PM – 2:50 PM Session 2 

“Real-World Evidence and the Transformational Role of Digital Health”

This panel will discuss new digital health solutions for capturing and surfacing real-world evidence across siloed stakeholders. The panelists will discuss the application of data to impact patient care and the use of emerging technologies to provide the life sciences industry with insights that could transform current approaches to personalized medicine and clincal trials. Panelists with backgrounds in big data, AI, engineering and financial services, together with extensive clinical operations expertise, will discuss how digital health, machine learning, blockchain and asset-backed securities can reshape the life sciences sector through technology that delivers far more precise and actionable patient insights and provide alternative funding strategies as well.

  • Moderator: Kimberly Ha (CEO, KKH Advisors)

 

2:50 PM – 3:10 PM Break

3:10 PM – 4:00 PM Session 3

“Continued M&A Deals as the Recalibration of the Industry”

Mergers-and acquisitions (M&A) activity has become the dominant force shaping the global pharmaceutical and biotech industries and the number keeps growing as a result of recent challenges including decrease in R&D productivity. This session will gather industry experts to discuss about current trends and issues in M&A as it will improve the overall outlook of these sectors and continue to be a key growth strategy to acquire new drugs and technology.

  • Moderator: Yiqin Shen (Senior Reporter, Mergermarket)

 

4:00 PM – 4:30 PM Award Ceremony & Networking

WMSG Contribution Award

*List of Panelists

  • Robert Chu (CEO & Founder, Embleema)
  • Ariel Katz (Chief Product Officer, H1)
  • Kara Dennis (SVP and GM of Life Sciences, Clarify Health)
  • Peter Lyons (Chief Innovation Officer, Atomic Capital)
  • Young Moon (Senior Consultant, W Medical Strategy Group)
  • Vincent Liu (Senior Advisor, Fosun Pharma)
  • Jamie Metzl (Senior Fellow, Atlantic Council)
  • Jeff Clark (CLO, Enzychem Lifesciences)

New York Health Forum (NYHF) is founded to strengthen healthcare partnerships and knowledge sharing at all levels, including industry, academia, medical and research facilities, service providers and financial investors. New York Health Forum’s mission is to present the significant agendas for healthcare industry, to contribute to public health by bringing out the public concerns to be discussed and solved; and to gather the sound of health policy, science innovation and industry development. Our 6th New York Health Forum’s title is “Korea Rise: New Strategies Transforming Korean Biopharma and Unparalleled Opportunities for Collaboraion” This forum will provide the setting for stimulating and informative discussions on the investment trends, landscapes, risks, and more. Around one hundred of investors, biopharma and medtech representatives, healthcare professionals will come together to connect, learn, and share.